News from cytosorbents corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( Bloomberg:RTRKS,RICS:RTRKS)

May 04, 2015, 07:00 ET
CytoSorbents Logo.

CytoSorbents to Report Q1 2015 Operating and Financial Results

CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Apr 27, 2015, 09:00 ET
CytoSorbents Logo.

CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director

 CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy commercializing its CytoSorb® extracorporeal cytokine...

Apr 24, 2015, 08:00 ET
CytoSorbents Logo

CytoSorbents Issues Letter to Shareholders

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb®...

Apr 14, 2015, 07:00 ET
CytoSorbents Logo.

CytoSorbents to Present at the 14th Annual Needham Healthcare Conference

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company using blood purification to treat deadly inflammation in...

Apr 07, 2015, 08:01 ET
CytoSorbents Logo.

CytoSorbents Issues Responses to Frequently Asked Questions

 CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company using blood purification to treat critically-ill and cardiac...

Mar 31, 2015, 16:50 ET
CytoSorbents Logo

CytoSorbents Reports Record 2014 Revenue

CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company using blood purification to treat critically-ill and cardiac...

Mar 24, 2015, 07:00 ET
CytoSorbents Logo.

CytoSorbents to Report Fiscal 2014 Operating and Financial Results

 CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Mar 13, 2015, 08:30 ET
CytoSorbents Logo.

CytoSorbents Plans Robust Agenda at ISICEM 2015

 CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy commercializing its CytoSorb® extracorporeal cytokine...

Mar 11, 2015, 08:30 ET
CytoSorbents Logo.

CytoSorbents Launches New International CytoSorb® Therapy Product Website

CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Feb 02, 2015, 07:00 ET
CytoSorbents Logo.

CytoSorbents Announces FDA Approval to Commence Initial U.S. Cardiac Surgery Study

 CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Jan 30, 2015, 07:00 ET
CytoSorbents Logo.

CytoSorbents And Aferetica Introduce CytoSorb® to Italy

 CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Jan 23, 2015, 07:00 ET
CytoSorbents Logo.

CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program

 CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal...

Jan 14, 2015, 09:00 ET
CytoSorbents Logo.

CytoSorbents Announces Closing of Public Offering

CytoSorbents Corporation (NASDAQ: CTSO) today announced the closing of a $10.3 million underwritten public offering of 1,250,000 shares of common...

Jan 07, 2015, 09:00 ET
CytoSorbents Logo.

CytoSorbents To Present at OneMedForum 2015 and Exhibit at the 44th Society of Critical Care Medicine Congress

 CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Dec 30, 2014, 07:15 ET
CytoSorbents Logo.

CytoSorbents Submits IDE Application to FDA for U.S. CytoSorb® Cardiac Surgery Trial

 CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Dec 23, 2014, 07:00 ET
CytoSorbents Logo

CytoSorbents Corporation Begins NASDAQ Trading Today

 CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Dec 22, 2014, 07:00 ET
CytoSorbents Logo.

CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development

 CytoSorbents Corporation (OTCQB:CTSOD), a critical care focused immunotherapy company marketing its CytoSorb® blood purification...

Dec 18, 2014, 07:00 ET
CytoSorbents Logo.

CytoSorbents Receives NASDAQ Listing Approval

 CytoSorbents Corporation (OTCQB: CTSOD), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Dec 17, 2014, 11:34 ET

CytoSorbents kündigt strategische Partnerschaft mit Fresenius Medical Care an

 CytoSorbents Corporation (OTCQB: CTSOD), ein führendes Unternehmen auf den Gebieten Immuntherapie und Blutreinigung in der...

Dec 16, 2014, 21:55 ET

CytoSorbents conclut un partenariat stratégique avec Fresenius Medical Care

 CytoSorbents Corporation (OTCQB: CTSOD), leader dans le domaine de l'immunothérapie pour soins intensifs et de la purification du sang,...